Cochrane Abstracts
Optimisation of antiretroviral therapy in HIV‐infected children under 3 years of age
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Optimisation of Antiretroviral Therapy in HIV‐infected Children Under 3 Years of Age." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433576/all/Optimisation_of_antiretroviral_therapy_in_HIV‐infected_children_under_3_years_of_age.
Optimisation of antiretroviral therapy in HIV‐infected children under 3 years of age. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433576/all/Optimisation_of_antiretroviral_therapy_in_HIV‐infected_children_under_3_years_of_age. Accessed December 6, 2024.
Optimisation of antiretroviral therapy in HIV‐infected children under 3 years of age. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433576/all/Optimisation_of_antiretroviral_therapy_in_HIV‐infected_children_under_3_years_of_age
Optimisation of Antiretroviral Therapy in HIV‐infected Children Under 3 Years of Age [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433576/all/Optimisation_of_antiretroviral_therapy_in_HIV‐infected_children_under_3_years_of_age.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Optimisation of antiretroviral therapy in HIV‐infected children under 3 years of age
ID - 433576
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433576/all/Optimisation_of_antiretroviral_therapy_in_HIV‐infected_children_under_3_years_of_age
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
